Trial Profile
Influence of genetic polymorphism of CYP2C19 on pharmacokinetics and pharmacodynamics of clopidogrel therapy in Indian population
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Cardiovascular disorders; Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics; Pharmacogenomic
- 01 Oct 2013 New trial record